Epidemiology and natural history of NAFLD and NASH - PubMed (original) (raw)
Review
. 2007 Feb;11(1):1-16, vii.
doi: 10.1016/j.cld.2007.02.009.
Affiliations
- PMID: 17544968
- DOI: 10.1016/j.cld.2007.02.009
Review
Epidemiology and natural history of NAFLD and NASH
Janus P Ong et al. Clin Liver Dis. 2007 Feb.
Abstract
Understanding of the epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD) has increased; it is the most common form of chronic liver disease in the Western world and increasing in importance in other parts of the world. Prevalence is expected to increase as obesity and diabetes epidemics evolve. The natural history of NAFLD depends on the histologic subtype. Those who have simple hepatic steatosis or nonspecific inflammation generally have a benign long-term prognosis, whereas non-alcoholic steatohepatitis (NASH) can progress to cirrhosis. NASH-related cirrhosis may have a similar prognosis as cirrhosis from other causes, leading to liver failure or hepatocellular carcinoma.
Similar articles
- Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis.
Serfaty L, Lemoine M. Serfaty L, et al. Diabetes Metab. 2008 Dec;34(6 Pt 2):634-7. doi: 10.1016/S1262-3636(08)74597-X. Diabetes Metab. 2008. PMID: 19195623 - Nonalcoholic fatty liver disease.
Hjelkrem MC, Torres DM, Harrison SA. Hjelkrem MC, et al. Minerva Med. 2008 Dec;99(6):583-93. Minerva Med. 2008. PMID: 19034256 Review. - Non-alcoholic steatohepatitis in children.
Nanda K. Nanda K. Pediatr Transplant. 2004 Dec;8(6):613-8. doi: 10.1111/j.1399-3046.2004.00241.x. Pediatr Transplant. 2004. PMID: 15598336 Review. - [Non-alcoholic fatty liver].
Tagle Arrospide M. Tagle Arrospide M. Rev Gastroenterol Peru. 2003 Jan-Mar;23(1):49-57. Rev Gastroenterol Peru. 2003. PMID: 12768215 Review. Spanish. - Non-alcoholic fatty liver disease and hepatitis C infection.
Bondini S, Younossi ZM. Bondini S, et al. Minerva Gastroenterol Dietol. 2006 Jun;52(2):135-43. Minerva Gastroenterol Dietol. 2006. PMID: 16557185 Review.
Cited by
- Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: A systematic review and meta-analysis.
Wu S, Wu F, Ding Y, Hou J, Bi J, Zhang Z. Wu S, et al. Sci Rep. 2016 Sep 16;6:33386. doi: 10.1038/srep33386. Sci Rep. 2016. PMID: 27633274 Free PMC article. Review. - Epidemiology and Natural History of Non-alcoholic Fatty Liver Disease.
Mishra A, Younossi ZM. Mishra A, et al. J Clin Exp Hepatol. 2012 Jun;2(2):135-44. doi: 10.1016/S0973-6883(12)60102-9. Epub 2012 Jul 21. J Clin Exp Hepatol. 2012. PMID: 25755422 Free PMC article. - Gut microbiome and liver disease.
Betrapally NS, Gillevet PM, Bajaj JS. Betrapally NS, et al. Transl Res. 2017 Jan;179:49-59. doi: 10.1016/j.trsl.2016.07.005. Epub 2016 Jul 15. Transl Res. 2017. PMID: 27477080 Free PMC article. Review. - Pre-transplant diabetes mellitus is a risk factor for non-relapse mortality, especially infection-related mortality, after allogeneic hematopoietic SCT.
Takano K, Fuji S, Uchida N, Ogawa H, Ohashi K, Eto T, Sakamaki H, Morishima Y, Kato K, Suzuki R, Fukuda T. Takano K, et al. Bone Marrow Transplant. 2015 Apr;50(4):553-8. doi: 10.1038/bmt.2014.315. Epub 2015 Jan 26. Bone Marrow Transplant. 2015. PMID: 25621798 Clinical Trial. - Hypoadiponectinemia and its association with liver fibrosis in morbidly obese patients.
Nazal L, Riquelme A, Solís N, Pizarro M, Escalona A, Burotto M, Méndez JI, Saint-Jean C, Concha MJ, Giovanni S, Awruch D, Morales A, Baudrand R, Carrasco G, Domínguez MA, Padilla O, Espinoza M, Miquel JF, Nervi F, Arrese M. Nazal L, et al. Obes Surg. 2010 Oct;20(10):1400-7. doi: 10.1007/s11695-009-0051-0. Epub 2010 Jan 12. Obes Surg. 2010. PMID: 20066503
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical